Targeting signaling pathways involved in primordial follicle growth or dormancy: potential application in prevention of follicular loss and infertility

References

• Adhikari D, Liu K. Molecular mechanisms underlying the activation of mammalian primordial follicles. Endocr Rev. 2009 Aug;30(5):438–464.
   PubMed Web of Science ®Google Scholar
• Pankhurst MW. A putative role for anti-Müllerian hormone (AMH) in optimising ovarian reserve expenditure. J Endocrinol. 2017 Apr;233(1):R1–r13.
   PubMed Web of Science ®Google Scholar
• Kevenaar M. The role of Anti-Müllerian hormone in ovarian function, dysfunction and aging [Ph.D. thesis]: Erasmus university rotterdam; 2008.
   Google Scholar
• Tingen CM, Bristol-Gould SK, Kiesewetter SE, et al. Prepubertal primordial follicle loss in mice is not due to classical apoptotic pathways. Biol Reprod. 2009 Jul;81(1):16–25.
   PubMed Web of Science ®Google Scholar
• McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000 Apr;21(2):200–214.
   PubMed Web of Science ®Google Scholar
• te Velde ER, Dorland M, Broekmans FJ. Age at menopause as a marker of reproductive ageing. Maturitas. 1998 Oct 12;30(2):119–125.
   PubMed Web of Science ®Google Scholar
• Gold EB. The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am. 2011 Sep;38(3):425–440.
   PubMed Web of Science ®Google Scholar
• Conway GS. Premature ovarian failure. Br Med Bull. 2000;56(3):643–649.
   PubMed Web of Science ®Google Scholar
• Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev. 1997 Feb;18(1):107–134.
   PubMed Web of Science ®Google Scholar
• Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006 Apr;6(1):9.
   Google Scholar
• Komorowska B. Autoimmune premature ovarian failure. Prz Menopauzalny. 2016 Dec;15(4):210–214.
   PubMedGoogle Scholar
• Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986 Apr;67(4):604–606.
   PubMed Web of Science ®Google Scholar
• Torrealday S, Kodaman P, Pal L. Premature ovarian insufficiency - an update on recent advances in understanding and management. F1000Res. 2017;6:2069.
   PubMedGoogle Scholar
• Sarrel PM, Sullivan SD, Nelson LM. Hormone replacement therapy in young women with surgical primary ovarian insufficiency. Fertil Steril. 2016 Dec;106(7):1580–1587.
   PubMed Web of Science ®Google Scholar
• Morgan S, Anderson RA, Gourley C, et al. How do chemotherapeutic agents damage the ovary? Hum reprod update. 2012 Sep-Oct;18(5):525–535.
   PubMed Web of Science ®Google Scholar
• Dragojević-Dikić S, Vasiljević M, Nikolić B, et al. Premature ovarian failure: immunological aspects and therapeutic strategies. Vojnosanit Pregl. 2013 Nov;70(11):1051–1055.
   PubMed Web of Science ®Google Scholar
• Qin Y, Jiao X, Simpson JL, et al. Genetics of primary ovarian insufficiency: new developments and opportunities. Hum Reprod Update. 2015 Nov-Dec;21(6):787–808.
   PubMed Web of Science ®Google Scholar
• Vabre P, Gatimel N, Moreau J, et al. Environmental pollutants, a possible etiology for premature ovarian insufficiency: a narrative review of animal and human data. Environ Health. 2017 Apr 7;16(1):37.
   PubMedGoogle Scholar
• Ebrahimi M, Akbari Asbagh F. Pathogenesis and causes of premature ovarian failure: an update. Int J Fertil Steril. 2011 Jul;5(2):54–65.
   PubMed Web of Science ®Google Scholar
• Colafrancesco S, Perricone C, Tomljenovic L, et al. Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants. Am J Reprod Immunol. 2013 Oct;70(4):309–316.
   PubMed Web of Science ®Google Scholar
• Little DT, Ward HRG. Adolescent premature ovarian insufficiency following human papillomavirus vaccination: A case series seen in general practice. J Investig Med High Impact Case Rep. 2014;2(4):2324709614556129.
   Google Scholar
• Sutherland J, Frost E, Ford E, et al. Janus Kinase JAK1 maintains the ovarian reserve of primordial follicles in the mouse ovary. Mol Hum Reprod. 2018;09/24:533–542.
   Web of Science ®Google Scholar
• Chen Y, Yang W, Shi X, et al. The factors and pathways regulating the activation of mammalian primordial follicles in vivo. Front Cell Dev Biol. 2020. 2020 Sept 30 8: (1018)10.3389/fcell.2020.575706. .
   Google Scholar
• Thomas F, Vanderhyden B. Oocyte-granulosa cell interactions during mouse follicular development: regulation of kit ligand expression and its role in oocyte growth. ReprodBiol Endocrinol. 2006 Feb 01; 4(1):19.
   PubMedGoogle Scholar
• Hsueh AJ, Kawamura K, Cheng Y, et al. Intraovarian control of early folliculogenesis. Endocr Rev. 2015 Feb;36(1):1–24.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu K. Cellular and molecular regulation of the activation of mammalian primordial follicles: somatic cells initiate follicle activation in adulthood. Hum Reprod Update. 2015 Aug 01; 21(6):779–786.
   PubMed Web of Science ®Google Scholar
• Lamming DW, Lamming DW. Inhibition of the mechanistic target of rapamycin (mTOR)–rapamycin and beyond. Cold Spring Harb Perspect Med. 2016;6(5):a025924.
   PubMed Web of Science ®Google Scholar
• Wang N, Li H, Zhu Y, et al. Melatonin protects against Epirubicin-induced ovarian damage. J Reprod Dev. 2020;66(1):19–27.
   PubMed Web of Science ®Google Scholar
• Di Emidio G, Rossi G, Bonomo I, et al. The natural carotenoid crocetin and the synthetic tellurium compound AS101 protect the ovary against cyclophosphamide by modulating SIRT1 and mitochondrial markers. Oxid Med Cell Longev. 2017 [2017 Nov 15];2017:8928604.
   PubMed Web of Science ®Google Scholar
• Mizunuma H, Liu X, Andoh K, et al. Activin from secondary follicles causes small preantral follicles to remain dormant at the resting stage. Endocrinology. 1999 Jan;140(1):37–42.
   PubMed Web of Science ®Google Scholar
• Chen ZG, Luo LL, Xu JJ, et al. Effects of plant polyphenols on ovarian follicular reserve in aging rats. Biochem Cell Biol. 2010 Aug;88(4):737–745.
   PubMedGoogle Scholar
• Zhang T, He M, Zhao L, et al. HDAC6 regulates primordial follicle activation through mTOR signaling pathway. Cell Death Dis. 2021 [2021 May 29];12(6):559.
   PubMed Web of Science ®Google Scholar
• Pascuali N, Scotti L, Pietro M, et al. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure. Hum Reprod. 2018 March 09 33(5):844–859.
   PubMed Web of Science ®Google Scholar
• Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction. 2002 Nov;124(5):601–609.
   PubMed Web of Science ®Google Scholar
• Kushnir VA, Seifer DB, Barad DH, et al. Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine. J Assist Reprod Genet. 2017 Sep;34(9):1105–1113.
   PubMed Web of Science ®Google Scholar
• Rawlings JS, Rosler KM, Harrison DA. The JAK/STAT signaling pathway. J Cell Sci. 2004;117(8):1281–1283.
   PubMed Web of Science ®Google Scholar
• Brosens JJ, Wilson MS, Lam EW. FOXO transcription factors: from cell fate decisions to regulation of human female reproduction. Adv Exp Med Biol. 2009;665:227–241.
   PubMed Web of Science ®Google Scholar
• Cui C, Han S, Yin H, et al. FOXO3 is expressed in ovarian tissues and acts as an apoptosis initiator in granulosa cells of chickens. Biomed Res Int. 2019 [Jul 11];2019:6902906.
   PubMed Web of Science ®Google Scholar
• Lloyd RV, Erickson LA, Jin L, et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999;154(2):313–323.
   PubMed Web of Science ®Google Scholar
• Li C, Liu Z, Wu G, et al. FOXO1 mediates hypoxia-induced G0/G1 arrest in ovarian somatic granulosa cells by activating the TP53INP1-p53-CDKN1A pathway. Development. 2021;148(14):14.
   Web of Science ®Google Scholar
• Liu L, Rajareddy S, Reddy P, et al. Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a. Development. 2007;134(1):199–209.
   PubMed Web of Science ®Google Scholar
• Takeuchi A, Koga K, Satake E, et al. Endometriosis triggers excessive activation of primordial follicles via PI3K-PTEN-Akt-Foxo3 pathway. J Clin Endocrinol Metab. 2019;104(11):5547–5554.
   PubMed Web of Science ®Google Scholar
• Pelosi E, Omari S, Michel M, et al. Constitutively active Foxo3 in oocytes preserves ovarian reserve in mice. Nat Commun. 2013 May 14;4(1):1843.
   PubMedGoogle Scholar
• Blanco-Aparicio C, Renner O, Leal JFM, et al. PTEN, more than the AKT pathway. Carcinogenesis. 2007;28(7):1379–1386.
   PubMed Web of Science ®Google Scholar
• Yang Q, Guan KL. Expanding mTOR signaling. Cell Res. 2007 Aug;17(8):666–681.
   PubMed Web of Science ®Google Scholar
• Grosbois J, Demeestere I. Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation. Hum Reprod. 2018;33(9):1705–1714.
   PubMed Web of Science ®Google Scholar
• Masciangelo R, Hossay C, Chiti MC, et al. Role of the PI3K and Hippo pathways in follicle activation after grafting of human ovarian tissue. J Assist Reprod Genet. 2020;37(1):101–108.
   PubMed Web of Science ®Google Scholar
• Massagué J, Chen Y-G. Massagué J, Chen YG. Controlling. TGF-beta signaling. Genes Dev.2000 Mar 15;14(6):627–644.
   PubMed Web of Science ®Google Scholar
• Wang ZP, Mu XY, Guo M, et al. Transforming growth factor-β signaling participates in the maintenance of the primordial follicle pool in the mouse ovary. J Biol Chem. 2014 Mar 21;289(12):8299–8311.
   PubMed Web of Science ®Google Scholar
• Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction. 2006 Aug;132(2):191–206.
   PubMed Web of Science ®Google Scholar
• Fauser BCJM, van Heusden AM. Manipulation of human ovarian function: Physiological concepts and clinical consequences*. Endocr Rev. 1997;18(1):71–106.
   PubMed Web of Science ®Google Scholar
• Pangas SA. Regulation of the ovarian reserve by members of the transforming growth factor beta family. Mol Reprod Dev. 2012 Oct;79(10):666–679.
   PubMed Web of Science ®Google Scholar
• Skinner MK. Regulation of primordial follicle assembly and development. Hum Reprod Update. 2005;11(5):461–471.
   PubMed Web of Science ®Google Scholar
• Zheng W, Zhang H, Liu K. The two classes of primordial follicles in the mouse ovary: their development, physiological functions and implications for future research. Mol Hum Reprod. 2014;20(4):286–292.
   PubMed Web of Science ®Google Scholar
• Rädler PD, Wehde BL, Wagner K-U. Crosstalk between STAT5 activation and PI3K/AKT functions in normal and transformed mammary epithelial cells. Mol Cell Endocrinol. 2017;451:31–39.
   PubMed Web of Science ®Google Scholar
• Weiler SR, Mou S, DeBerry CS, et al. JAK2 is associated with the c-kit proto-oncogene product and is phosphorylated in response to stem cell factor. Blood. 1996 May 01 87(9):3688–3693.
   PubMed Web of Science ®Google Scholar
• Parrott JA, Skinner MK. Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis. Endocrinology. 1999 Sep;140(9):4262–4271.
   PubMed Web of Science ®Google Scholar
• Rönnstrand L. Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol Life Sci. 2004;61(19):2535–2548.
   PubMed Web of Science ®Google Scholar
• John GB, Shidler MJ, Besmer P, et al. Kit signaling via PI3K promotes ovarian follicle maturation but is dispensable for primordial follicle activation. Dev Biol. 2009 Jul 15; 331(2):292–299.
   PubMed Web of Science ®Google Scholar
• Ezzati M, Baker M, Aloisio G, et al. Regulation of foxo3 subcellular localization by kit ligand in the neonatal mouse ovary. Fertil Steril. 2014;102(3):e117–e18.
   Web of Science ®Google Scholar
• Devos M, Grosbois J, Demeestere I. Interaction between PI3K/AKT and Hippo pathways during in vitro follicular activation and response to fragmentation and chemotherapy exposure using a mouse immature ovary model. Biol Reprod. 2019;102(3):717–729. 13.
   Web of Science ®Google Scholar
• Runyan CE, Schnaper HW, Poncelet AC. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem. 2004 Jan 23;279(4):2632–2639.
   PubMed Web of Science ®Google Scholar
• Bakin AV, Tomlinson AK, Bhowmick NA, et al. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem. 2000 Nov 24;275(47):36803–36810.
   PubMed Web of Science ®Google Scholar
• Thomas FH, Ethier J-F, Shimasaki S, et al. Follicle-stimulating hormone regulates oocyte growth by modulation of expression of oocyte and granulosa cell factors. Endocrinology. 2005;146(2):941–949.
   PubMed Web of Science ®Google Scholar
• Otsuka F, Shimasaki S. A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis. Proc Nat Acad Sci. 2002; 99(12):8060–8065.
   PubMed Web of Science ®Google Scholar
• Zhang H, Risal S, Gorre N, et al. Somatic cells initiate primordial follicle activation and govern the development of dormant oocytes in mice. Curr Biol. 2014;24(21):2501–2508.
   PubMed Web of Science ®Google Scholar
• Guo Z, Yu Q, Huang Z. Role of mTOR signaling in female reproduction. Front Endocrinol (Lausanne). 2019;10:10.
   PubMed Web of Science ®Google Scholar
• Adhikari D, Risal S, Liu K, et al. Pharmacological inhibition of mTORC1 prevents over-activation of the primordial follicle pool in response to elevated PI3K signaling. PloS one. 2013;8(1):e53810.
   PubMed Web of Science ®Google Scholar
• Celik S, Ozkavukcu S, Celik-Ozenci C. Altered expression of activator proteins that control follicle reserve after ovarian tissue cryopreservation/transplantation and primordial follicle loss prevention by rapamycin. J Assist Reprod Genet. 2020 Sep;37(9):2119–2136.
   PubMed Web of Science ®Google Scholar
• Novella-Maestre E, Herraiz S, Rodríguez-Iglesias B, et al. PTEN inhibition improves in vitro activation of primordial follicles, preserves follicular viability, and restores AMH levels in cryopreserved ovarian tissue from cancer patients. PLoS One. 2015;10(5):e0127786.
   PubMed Web of Science ®Google Scholar
• Makker A, Goel MM, Mahdi AA. PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: an update. J Mol Endocrinol. 2014;53(3):R103–R18.
   PubMed Web of Science ®Google Scholar
• Jang H, Hong K, Choi Y. Melatonin and fertoprotective adjuvants: prevention against premature ovarian failure during chemotherapy. Int J Mol Sci. 2017 Jun 07; 18(6):1221.
   PubMed Web of Science ®Google Scholar
• Jang H, Lee O-H, Lee Y, et al. Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN/AKT/FOXO3a pathway activation in the mouse ovary. J Pineal Res. 2016;60(3):336–347.
   PubMed Web of Science ®Google Scholar
• Sredni B, Weil M, Khomenok G, et al. Ammonium trichloro(dioxoethylene-o,o′)tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop. Cancer Res. 2004;64(5):1843–1852.
   PubMed Web of Science ®Google Scholar
• Kalich-Philosoph L, Roness H, Carmely A, et al. Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5(185):185ra62–85ra62.
   PubMed Web of Science ®Google Scholar
• Spears N, Lopes F, Stefansdottir A, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019;25(6):673–693.
   PubMed Web of Science ®Google Scholar
• Bertoldo MJ, Bernard J, Duffard N, et al. Régulation de la croissance des follicules pré-antraux, un frein à l’épuisement de la réserve ovarienne. Gynécologie Obstétrique & Fertilité. 2013 Sep 01. 41: 9. 540–543. 2013.
   PubMedGoogle Scholar
• Haddad YH, Said RS, Kamel R, et al. Phytoestrogen genistein hinders ovarian oxidative damage and apoptotic cell death-induced by ionizing radiation: co-operative role of ER-β, TGF-β, and FOXL-2.Sci Rep. 2020 [2020 Aug 11];10(1):13551.
   PubMed Web of Science ®Google Scholar
• Saleh DO, Mansour DF. Ovario-protective effects of genistein against cyclophosphamide toxicity in rats: role of anti-müllerian hormone and oestradiol. Eur J Pharmacol. 2016;789:163–171.
   PubMed Web of Science ®Google Scholar
• Gomez-Muñoz A, Gangoiti P, Arana L, et al. New insights on the role of ceramide 1-phosphate in inflammation. Biochim Biophys Acta. 2013 Jun;1831(6):1060–1066.
   PubMed Web of Science ®Google Scholar
• Durlinger A. Ovarian follicle growth and development: role of anti-Müllerian hormone [Ph.D. thesis]: Erasmus university rotterdam; 2000.
   Google Scholar
• Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update. 2014;20(3):370–385.
   PubMed Web of Science ®Google Scholar
• Weenen C, Laven JSE, ARM VB, et al. Anti‐Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77–83.
   PubMed Web of Science ®Google Scholar
• Jamil Z, Fatima SS, Ahmed K, et al. Anti-Mullerian hormone: Above and beyond conventional ovarian reserve markers. Dis Markers. 2016;2016:5246217.
   PubMed Web of Science ®Google Scholar
• Beau I, Sonigo C, Binart N. OR20-01 AMH preserves fertility in chemotherapy-treated mice through a mechanism involving autophagy. J Endocr Soc. 2020;4(1). 10.1210/jendso/bvaa046.485
   Google Scholar
• Sonigo C, Beau I, Grynberg M, et al. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice. FASEB J. 2019 Jan;33(1):1278–1287.
   PubMed Web of Science ®Google Scholar
• Durlinger ALL, Gruijters MJG, Kramer P, et al, Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology. 2002;143(3):1076–1084.
   PubMed Web of Science ®Google Scholar
• Ramezani Tehrani F, Solaymani-Dodaran M, Hedayati M, et al. Is polycystic ovary syndrome an exception for reproductive aging? Hum Reprod. 2010;25(7):1775–1781.
   PubMed Web of Science ®Google Scholar
• Campbell BK, Clinton M, Webb R. The role of anti-Müllerian hormone (AMH) during follicle development in a monovulatory species (sheep). Endocrinology. 2012 Sep;153(9):4533–4543.
   PubMed Web of Science ®Google Scholar
• Kano M, Sosulski AE, Zhang L, et al. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proc Nat Acad Sci. 2017 114(9):E1688–E97.
   PubMed Web of Science ®Google Scholar
• Roness H, Spector I, Leichtmann-Bardoogo Y, et al. Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects. J Assist Reprod Genet. 2019 Sep;36(9):1793–1803.
   PubMed Web of Science ®Google Scholar
• Carlsson IB, Scott JE, Visser JA, et al. Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod. 2006 Sep;21(9):2223–2227.
   PubMed Web of Science ®Google Scholar
• McGee EA, Smith R, Spears N, et al. Müllerian inhibitory substance induces growth of rat preantral ovarian follicles. Biol Reprod. 2001 Jan;64(1):293–298.
   PubMed Web of Science ®Google Scholar
• Schmidt KL, Kryger-Baggesen N, Byskov AG, et al. Anti-Müllerian hormone initiates growth of human primordial follicles in vitro. Mol Cell Endocrinol. 2005 Apr 29;234(1–2):87–93.
   PubMed Web of Science ®Google Scholar
• Zhang J-M, Lu X-L, Wang H-X. Inhibition of mTORC1 signaling pathway is a valid therapeutic strategy in transplantation of cryopreserved mouse ovarian tissue. Cryoletters. 2020;41(1):38–43.
   PubMed Web of Science ®Google Scholar
• Ma M, Chen X-Y, Li B, et al. Melatonin protects premature ovarian insufficiency induced by tripterygium glycosides: role of SIRT1. Am J Transl Res. 2017;04/15(9):1580–1602.
   Google Scholar
• Roy S, Gandra D, Seger C, et al. Oocyte-derived factors (GDF9 and BMP15) and FSH regulate AMH expression via modulation of H3K27AC in granulosa cells. Endocrinology. 2018;159(9):3433–3445.
   PubMed Web of Science ®Google Scholar
• Woodhams EJ, Gilliam M. Contraception. Ann Intern Med. 2019 Feb 5;170(3):Itc18–itc32.
   PubMed Web of Science ®Google Scholar
• Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol. 1999 Nov;181(5 Pt 1):1263–1269.
   PubMed Web of Science ®Google Scholar
• Hayes E, Kushnir V, Ma X, et al. Intra-cellular mechanism of Anti-Müllerian hormone (AMH) in regulation of follicular development. Mol Cell Endocrinol. 2016 Sep;15(433):56–65.
   Google Scholar